VRCA logo

Verrica Pharmaceuticals (VRCA) EBITDA

Annual EBITDA

-$62.20 M
-$40.60 M-187.99%

December 31, 2023

Summary

Performance

1-Year Change

-187.99%

3-Year Change

-57.74%

5-Year Change

-184.55%

15-Year Change

-1295.49%

VRCA EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

28.32%
VRCA annual EBITDA is higher than 28.32% of companies in Healthcare sector

High & Low

All-time High

-$1.91 M

3-Year Low

-$62.20 M
VRCA annual EBITDA is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
VRCA previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Feb 28, 2025
VRCA next annual earnings announcement is scheduled for Feb 28, 2025

OtherVRCAprofitabilitymetrics:

Annual Revenue

$5.12 M
VRCA annual revenue is $5.12 million

Annual Net Income

-$67.00 M
VRCA annual net profit is -$67.00 million

Annual EBIT

-$63.03 M
VRCA annual earnings before interest & taxes is -$63.03 million

Annual EPS

-$1.48
VRCA annual earnings per share is -$1.48

Quarterly EBITDA

-$20.14 M
-$5.66 M-39.06%

September 30, 2024

Summary

Performance

3-Month Change

-39.06%

1-Year Change

+12.18%

3-Year Change

-251.46%

5-Year Change

-251.46%

VRCA Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

22.97%
VRCA quarterly EBITDA is higher than 22.97% of companies in Healthcare sector

High & Low

All-time High

$485.00 K
VRCA quarterly EBITDA is currently -4252.99% below its historical high of $485.00 thousand

3-Year Low

-$22.93 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
VRCA previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 28, 2025
VRCA next earnings announcement is scheduled for Feb 28, 2025

OtherVRCAprofitabilitymetrics:

Quarterly Revenue

-$1.78 M
VRCA quarterly revenue is -$1.78 million

Quarterly Net Income

-$22.86 M
VRCA quarterly net profit is -$22.86 million

Quarterly EBIT

-$20.48 M
VRCA quarterly earnings before interest & taxes is -$20.48 million

Quarterly EPS

-$0.49
VRCA quarterly earnings per share is -$0.49

TTM EBITDA

-$74.39 M
+$2.79 M+3.62%

September 30, 2024

Summary

Performance

3-Month Change

+3.62%

1-Year Change

-62.3%

3-Year Change

-245.36%

5-Year Change

-245.36%

VRCA TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

24.24%
VRCA TTM EBITDA is higher than 24.24% of companies in Healthcare sector

High & Low

All-time High

-$570.00 K

3-Year Low

-$77.18 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
VRCA previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 28, 2025
VRCA next earnings announcement is scheduled for Feb 28, 2025

OtherVRCAprofitabilitymetrics:

TTM Revenue

$9.21 M
VRCA TTM revenue is $9.21 million

TTM Net Income

-$84.99 M
VRCA TTM net profit is -$84.99 million

TTM EBIT

-$75.62 M
VRCA TTM earnings before interest & taxes is -$75.62 million

TTM EPS

-$1.84
VRCA TTM earnings per share is -$1.84

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Annual EBITDA

-$62.20 M
VRCA annual EBITDA is -$62.20 million

Annual Net Income

-$67.00 M
VRCA annual net profit is -$67.00 million

Annual Interest Expense

$3.96 M
VRCA annual interest expense is $3.96 million

Annual Income Tax

-
VRCA annual income tax value is unknown

Annual D&A

$836.00 K
VRCA annual depreciation & amortization is $836.00 thousand

VRCA EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-188.0%+12.2%-62.3%
3 y3 years-57.7%-251.5%-245.4%
5 y5 years-184.6%-251.5%-245.4%

VRCA EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-188.0%at low-4253.0%+12.2%-260.5%+3.6%
5 y5-year-188.0%at low-4253.0%+12.2%-260.5%+3.6%
alltimeall time-3151.3%at low-4253.0%+12.2%<-9999.0%+3.6%

Verrica Pharmaceuticals EBITDA History

DateAnnualQuarterlyTTM
Sep 2024
-
-$20.14 M(+39.1%)
-$74.39 M(-3.6%)
Jun 2024
-
-$14.48 M(-18.0%)
-$77.18 M(+5.0%)
Mar 2024
-
-$17.67 M(-20.0%)
-$73.48 M(+18.1%)
Dec 2023
-$62.20 M(+188.0%)
-$22.09 M(-3.7%)
-$62.20 M(+35.7%)
Sep 2023
-
-$22.93 M(+112.7%)
-$45.84 M(+104.5%)
Jun 2023
-
-$10.78 M(+68.8%)
-$22.42 M(+8.6%)
Mar 2023
-
-$6.39 M(+11.4%)
-$20.64 M(-4.2%)
Dec 2022
-$21.60 M(-28.8%)
-$5.73 M(-1281.6%)
-$21.54 M(-9.8%)
Sep 2022
-
$485.00 K(-105.4%)
-$23.88 M(-33.8%)
Jun 2022
-
-$9.00 M(+23.5%)
-$36.05 M(-4.4%)
Mar 2022
-
-$7.29 M(-9.7%)
-$37.71 M(+24.4%)
Dec 2021
-$30.31 M(-23.1%)
-$8.07 M(-30.9%)
-$30.31 M(-10.9%)
Sep 2021
-
-$11.68 M(+9.6%)
-$34.03 M(+6.6%)
Jun 2021
-
-$10.66 M(<-9900.0%)
-$31.91 M(+7.3%)
Mar 2021
-
$103.00 K(-100.9%)
-$29.74 M(-24.6%)
Dec 2020
-$39.43 M
-$11.79 M(+23.3%)
-$39.43 M(+12.5%)
DateAnnualQuarterlyTTM
Sep 2020
-
-$9.56 M(+12.6%)
-$35.06 M(+11.1%)
Jun 2020
-
-$8.49 M(-11.4%)
-$31.57 M(+5.0%)
Mar 2020
-
-$9.59 M(+29.3%)
-$30.07 M(+7.6%)
Dec 2019
-$27.95 M(+27.9%)
-$7.42 M(+22.1%)
-$27.95 M(-2.6%)
Sep 2019
-
-$6.07 M(-13.1%)
-$28.71 M(-0.9%)
Jun 2019
-
-$6.99 M(-6.4%)
-$28.96 M(+5.6%)
Mar 2019
-
-$7.47 M(-8.7%)
-$27.44 M(+25.5%)
Dec 2018
-$21.86 M(+390.4%)
-$8.18 M(+29.3%)
-$21.86 M(+44.6%)
Sep 2018
-
-$6.33 M(+15.8%)
-$15.11 M(+49.0%)
Jun 2018
-
-$5.46 M(+189.5%)
-$10.14 M(+75.7%)
Mar 2018
-
-$1.89 M(+31.7%)
-$5.78 M(+29.6%)
Dec 2017
-$4.46 M(+133.0%)
-$1.43 M(+5.6%)
-$4.46 M(+47.4%)
Sep 2017
-
-$1.36 M(+24.0%)
-$3.02 M(+81.6%)
Jun 2017
-
-$1.09 M(+92.1%)
-$1.67 M(+192.1%)
Mar 2017
-
-$570.00 K
-$570.00 K
Dec 2016
-$1.91 M
-
-

FAQ

  • What is Verrica Pharmaceuticals annual EBITDA?
  • What is the all time high annual EBITDA for Verrica Pharmaceuticals?
  • What is Verrica Pharmaceuticals annual EBITDA year-on-year change?
  • What is Verrica Pharmaceuticals quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Verrica Pharmaceuticals?
  • What is Verrica Pharmaceuticals quarterly EBITDA year-on-year change?
  • What is Verrica Pharmaceuticals TTM EBITDA?
  • What is the all time high TTM EBITDA for Verrica Pharmaceuticals?
  • What is Verrica Pharmaceuticals TTM EBITDA year-on-year change?

What is Verrica Pharmaceuticals annual EBITDA?

The current annual EBITDA of VRCA is -$62.20 M

What is the all time high annual EBITDA for Verrica Pharmaceuticals?

Verrica Pharmaceuticals all-time high annual EBITDA is -$1.91 M

What is Verrica Pharmaceuticals annual EBITDA year-on-year change?

Over the past year, VRCA annual EBITDA has changed by -$40.60 M (-187.99%)

What is Verrica Pharmaceuticals quarterly EBITDA?

The current quarterly EBITDA of VRCA is -$20.14 M

What is the all time high quarterly EBITDA for Verrica Pharmaceuticals?

Verrica Pharmaceuticals all-time high quarterly EBITDA is $485.00 K

What is Verrica Pharmaceuticals quarterly EBITDA year-on-year change?

Over the past year, VRCA quarterly EBITDA has changed by +$2.79 M (+12.18%)

What is Verrica Pharmaceuticals TTM EBITDA?

The current TTM EBITDA of VRCA is -$74.39 M

What is the all time high TTM EBITDA for Verrica Pharmaceuticals?

Verrica Pharmaceuticals all-time high TTM EBITDA is -$570.00 K

What is Verrica Pharmaceuticals TTM EBITDA year-on-year change?

Over the past year, VRCA TTM EBITDA has changed by -$28.55 M (-62.30%)